Review
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2012; 18(3): 212-224
Published online Jan 21, 2012. doi: 10.3748/wjg.v18.i3.212
Figure 4
Figure 4 Insulin resistance predicts response to peginterferon-α/ribavirin combination therapy in chronic hepatitis C patients[106]. 1Statistical significance. SVR: Sustained virological response; HOMA-IR: Homeostasis model assessment-insulin resistance.